DealViolet Therapeutics, a Norwalk, CT-based preclinical neurodegeneration biotech, raised $4.75 million in a Seed extension fundraising round led by LifeSpan Vision Ventures with participation from Dementia Discovery Fund SV Health Investors and UTEC University of Tokyo Edge Capital Partners.
More on VCNewsDaily→
SEED
05/22/2026
Uresta Resilia Inc., a Shediac, Canada-based femtech for bladder leaks,...
Autoimmunity BioSolutions, a Houston-based autoimmune disease therapeutics...
Helsing, a Munich-based defense AI company, raised $1.2 billion in a...
Veritas Aortic Solutions, a Costa Mesa, CA-based non-surgical aortic...
Psilera, a Tampa, FL-based psychedelic neuroplastogen therapeutics...
Paralign Health, a United States-based EMS-led preventative care platform,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
